Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.
about
Applications of aptamers in targeted imaging: state of the artUltrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic CancerTherapeutic aptamers: developmental potential as anticancer drugsSelection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersCombined cancer photothermal-chemotherapy based on doxorubicin/gold nanorod-loaded polymersomesIdentification of epithelial ovarian tumor-specific aptamers.Ligand-targeted theranostic nanomedicines against cancerToward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.Selection of DNA nanoparticles with preferential binding to aggregated protein target.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Multifunctional nanoparticles: recent progress in cancer therapeutics.New developments in the early diagnosis of pancreatic cancer.Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast CancerSelf-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy.Prospects in the use of aptamers for characterizing the structure and stability of bioactive proteins and peptides in food.Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.
P2860
Q27011511-4A895279-1338-4241-9D43-364250249B39Q27300789-CEAC793E-AFBC-4A45-A4BD-787A86A66BEDQ28085157-43BE0FD6-26A3-44F8-8919-7C06C0E51939Q33832781-67BBB8E0-E03F-4DD0-BB1F-DBBBC479FE61Q35086497-30F40830-0E5C-4F44-9B12-0740C6920083Q35635298-44ECCB2B-C18A-443D-AB33-4871E2910799Q35895637-845C004B-2519-4AAE-88DF-93DF759DA0CBQ36946804-8ACB8A58-FD7E-475B-AA46-93113B44D1BEQ36959018-685167C6-3903-4C19-B0A3-48EA3503C1A3Q37422972-8356032A-3B75-43D7-954B-99AC18DA9608Q38491805-4A581F0A-4F57-4B7A-819A-1193439C9E96Q38559193-4E6800D0-6B40-4263-BADC-FCE07C0A62B3Q38784810-2E8323B0-1E10-49C5-A6D5-498C4200690FQ39096024-103771D6-DAB1-4917-85BF-DD9F59791CFAQ41661268-6F4E6A0B-A0BF-4D73-88A9-0A2546541794Q45875443-11A79701-81E6-42A1-A83E-9E38DAE287B2Q47701070-E3E75CB9-1048-45F7-BDAA-74BA1915C4A5Q49163466-6BA1A330-A164-427D-AFA8-062B7EC34796Q54457076-6C800E31-5FC5-4A46-82E4-61F76D41C3DE
P2860
Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Progress in aptamer-mediated d ...... g chemotherapeutic challenges.
@ast
Progress in aptamer-mediated d ...... g chemotherapeutic challenges.
@en
type
label
Progress in aptamer-mediated d ...... g chemotherapeutic challenges.
@ast
Progress in aptamer-mediated d ...... g chemotherapeutic challenges.
@en
prefLabel
Progress in aptamer-mediated d ...... g chemotherapeutic challenges.
@ast
Progress in aptamer-mediated d ...... g chemotherapeutic challenges.
@en
P2093
P2860
P921
P356
P1433
P1476
Progress in aptamer-mediated d ...... g chemotherapeutic challenges.
@en
P2093
P2860
P304
P356
10.7150/THNO.9663
P5008
P577
2014-07-13T00:00:00Z